Alternative Names:
FRAP; FRAP1; FRAP2; RAFT1; Rapamycin target protein; kinase mTOR;
Application:
WB IHC ICC/IF IP FC
Reactivity:
Human Mouse Rat
Dilution:
WB 1:500~1:1000 IHC 1:50~1:100 ICC/IF 1:50~1:100 IP 1:30 FC 1:20
| Western blot analysis of mTOR expression in Jurkat cell lysate. |
| Immunohistochemical analysis of paraffin-embedded rat liver, using mTOR Antibody. |
| Overexpression of the 14-3-3γ protein in uterine leiomyoma cells results in growth retardation and increased apoptosis. -Cellular Signalling |
| A brain somatic RHEB doublet mutation causes focal cortical dysplasia type II. -EXPERIMENTAL AND MOLECULAR MEDICINE |
| Taurine improves low‐level inorganic arsenic‐induced insulin resistance by activating PPARγ‐mTORC2 signalling and inhibiting hepatic autophagy. -JOURNAL OF CELLULAR PHYSIOLOGY |
| Prostaglandin E1 Inhibited Diabetes-Induced Phenotypic Switching of Vascular Smooth Muscle Cells Through Activating Autophagy. -Cellular Physiology and Biochemistry |
|
|
Purification:
Affinity-chromatography
Specificity:
mTOR Antibody detects endogenous levels of total mTOR
Immunogen:
A synthesized peptide derived from human mTOR
Description:
An atypical kinase belonging to the PIKK family of kinases. Controls cell growth through protein synthesis regulation. Downstream of PI3K/Akt pathway and required for cell survival. Acts as the target for the cell-cycle arrest and immunosuppressive effects of the FKBP12-rapamycin complex.
Storage Condition and Buffer:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at +4°C short term. Store at -20°C long term. Avoid freeze / thaw cycle.